US EditionPublished • loading... • Updated
Onconetix, Ocuvex announce mutual termination of merger agreement
Summary by ROI-NJ
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Onconetix, Ocuvex announce mutual termination of merger agreement
Onconetix Inc., a Cincinnati-based commercial-stage biotechnology company focused on innovative solutions for men’s health and oncology, and Ocuvex Therapeutics Inc., a Fort Lee-headquartered company focused on ophthalmic innovation, announced Sept. 26 the mutual termination of their previously announced definitive merger agreement, dated July 16. After careful consideration and constructive dialogue, both companies have jointly determined that …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
